(Q40748733)

23 September 2017

title

Evaluation of a measurement strategy for Parkinson's disease: assessing patient health-related quality of life (English)

1 reference

23 September 2017

1 reference

1 reference

Damiano AM

1

1 reference

23 September 2017

McGrath MM

2

1 reference

23 September 2017

Willian MK

3

1 reference

23 September 2017

Snyder CF

4

1 reference

23 September 2017

LeWitt PA

5

1 reference

23 September 2017

Reyes PF

6

1 reference

23 September 2017

Richter RR

7

1 reference

23 September 2017

Means ED

8

1 reference

23 September 2017

publication date

1 February 2000

1 reference

23 September 2017

published in

Quality of Life Research

1 reference

23 September 2017

volume

9

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

87-100

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1008928321652

23 September 2017

exact match

0 references

cites work

Parkinsonism: onset, progression, and mortality

1 reference

12 December 2020

Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group.

1 reference

12 December 2020

Quality of life in patients with Parkinson's disease: development of a questionnaire

1 reference

12 December 2020

Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39)

1 reference

12 December 2020

1 reference

12 December 2020

Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients

1 reference

12 December 2020

Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey.

1 reference

12 December 2020

A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease

1 reference

12 December 2020

Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: pharmacokinetic and quality-of-life measures.

1 reference

12 December 2020

Quality of life in patients with Parkinson's disease who transfer from standard levodopa to Sinemet CR: the STAR Study. The STAR Multicenter Study Group.

1 reference

12 December 2020

Self-reported health status and access to health services in a community sample with Parkinson's disease.

1 reference

12 December 2020

A review of health-related quality-of-life concepts and measures for Parkinson's disease

1 reference

12 December 2020

The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.

1 reference

12 December 2020

Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study

1 reference

12 December 2020

Quality of life and Parkinson's disease: the CR FIRST Study.

1 reference

12 December 2020

Quality of life and Parkinson's disease: translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39).

1 reference

12 December 2020

Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life

1 reference

12 December 2020

Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1008928321652

1 reference

Dimensions Publication ID

23 September 2017

1038587114

0 references

1 reference